Evidence map›Paper›PMID 37413908›Full record

ArticleThe International journal on drug policy2023

High-risk polysubstance use among LGBTQ+ people who use drugs in the United States: An application of syndemic theory.

Cory J Cascalheira, Jessie Nelson, Ryan E Flinn, Yuxuan Zhao, Emily C Helminen, Jillian R Scheer, Amy L Stone

Open access · greenAbstract read
In one paragraph

Article in The International journal on drug policy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Cory J CascalheiraDepartment of Counseling and Educational Psychology, New Mexico State University, Las Cruces, NM, USA; Department of Psychology, Syracuse University, Syracuse, NY, USA. Electronic address: cjcascalheira@gmail.com.
Jessie NelsonDepartment of Counseling and Educational Psychology, New Mexico State University, Las Cruces, NM, USA.
Ryan E FlinnDepartment of Psychiatry and Health Behavior, Medical College of Georgia, Augusta University, Augusta, GA, USA.
Yuxuan ZhaoDepartment of Counseling and Educational Psychology, New Mexico State University, Las Cruces, NM, USA.
Emily C HelminenDepartment of Psychology, Syracuse University, Syracuse, NY, USA.
Jillian R ScheerDepartment of Psychology, Syracuse University, Syracuse, NY, USA.
Amy L StoneDepartment of Sociology and Anthropology, Trinity University, San Antonio, TX, USA.
New Mexico State University · USSyracuse University · USAugusta University · USTrinity University · US

Funding

RISE PROGRAM AT NEW MEXICO STATE UNIVERSITYR25GM061222 · NIGMS · NEW MEXICO STATE UNIVERSITY LAS CRUCES · PI HOUSTON, JESSICA PEREA, REDDI, LAKSHMI · 2000 to 2022
$21.3M
UCLA Implementation Science and Substance Use Research and Education (ISSURE) ProgramR25DA035692 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TIMOTHY W FONG, GAIL E. WYATT · 2013 to 2026
$3.9M
The Lifespan/Brown Criminal Justice Research Program on Substance Use and HIVR25DA037190 · NIDA · MIRIAM HOSPITAL · PI CURT G BECKWITH · 2014 to 2026
$3.5M
G-RISE at New Mexico State UniversityT32GM148394 · NIGMS · NEW MEXICO STATE UNIVERSITY LAS CRUCES · PI Jessica Perea Houston, Charles Bradley Shuster · 2023 to 2026
$2.1M
Testing a Biopsychosocial Model of Violence Exposure, Minority Stressors, and Hazardous Drinking among Sexual Minority WomenK01AA028239 · NIAAA · UNIVERSITY OF RHODE ISLAND · PI SCHEER, JILLIAN R · 2021 to 2025
$1.0M
NIAAA NIH HHS K01 AA028239NIDA NIH HHS R25 DA035692NIDA NIH HHS R25 DA037190NIGMS NIH HHS R25 GM061222NIGMS NIH HHS T32 GM148394
6 · The paper itself

Abstract

backgroundCompared to heterosexual and cisgender people, lesbian, gay, bisexual, transgender, queer, and other sexual and gender minority (LGBTQ+) people are more likely to develop problems with high-risk polysubstance use. According to syndemic theory, this disparity in high-risk polysubstance use is produced by the LGBTQ+ community's increased vulnerability to experiencing psychosocial (e.g., discrimination, unwanted sex) and structural (e.g., food insecurity, homelessness) conditions, greater likelihood of coping with concurrent health problems (e.g., human immunodeficiency virus [HIV]), and decreased opportunities to develop protective factors (e.g., social support, resilience).

methodsData from 306 LGBTQ+ participants living in the United States (U.S.) with a lifetime history of alcohol and drug use were analyzed; 21.2% reported lifetime problems with 10 different drugs. Bootstrapped hierarchical multiple regression was used to test demographic correlates and syndemic predictors of high-risk polysubstance use. One-way ANOVA and post-hoc comparison tests were used to test subgroup differences by gender.

resultsResults indicated that income, food insecurity, sexual orientation-based discrimination, and social support were associated with high-risk polysubstance use, explaining 43.9% of the variance of high-risk polysubstance use. Age, race, unwanted sex, gender identity-based discrimination, and resilience were not significant. Group comparison tests revealed that, compared to nonbinary people and cisgender sexual minority men and women, transgender individuals experienced significantly higher levels of high-risk polysubstance use and sexual orientation-based discrimination but significantly lower levels of homelessness and social support.

conclusionThis study provided further evidence for conceptualizing polysubstance use as an adverse outcome of syndemic conditions. Harm reduction strategies, anti-discrimination laws, and gender-affirming residential treatment options should be considered in U.S. drug policy. Clinical implications include targeting syndemic conditions to reduce high-risk polysubstance use among LGBTQ+ people who use drugs.

Indexed as

Homosexuality, FemaleSexual and Gender MinoritiesTransgender PersonsFemaleGender IdentityHumansMaleSexual BehaviorSyndemicUnited StatesAlcoholGender identityIllicit drugsPolydrug useSexual and gender minoritySexual orientation

Identifiers

PMID37413908
PMCPMC10528101
OpenAlexW4383163182

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.